Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Gene therapy: same vector, same dose — up to 20 times more transgene.
Vector delivers the gene — the hepatocyte determines how efficiently it works.
At ISTH 2026, Denise Sabatino presented data identifying SUMOylation — a common host post-translational modification — as a restriction factor for transgene expression in AAV-transduced cells.
The agent: TAK-981 (subasumstat), a clinical-stage SUMO-activating enzyme inhibitor.
- In vitro: up to approximately 20 times higher transgene expression, across all cell types and promoters tested
- In vivo: around 36 times, 90 times and 200 times luciferase at days 1, 2 and 3
- Vector copy number lower while transgene mRNA and protein higher — driven not by increased vector uptake but by de-repression within the transduced cell
- Therapeutic transgenes: around 4 times FVIII (haemophilia A) and ~2× FIX-Padua (haemophilia B), including dosing months after transduction
- Effect transient and repeatable — a pharmacologically tunable intervention
SUMO-mediated restriction is an underappreciated limitation of AAV gene therapy, independent of serotype, promoter and transgene.
Modulating it may improve the durability and efficacy of expression — a relevant target for a field focused on long-term, predictable transgene output.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom